HOW TO KNOW IF ADVANCED
TREATMENTS MAY BE RELEVANT
Many patients hear about CAR-T, TIL therapy, immunotherapy, and clinical trials — but cannot tell if any apply to them. This guide explains exactly what doctors look at.
analyticsAt a Glance
- check_circleEligibility for advanced cancer treatment depends on diagnosis, molecular profile, and performance status
- check_circlePrior treatment history, organ function, and active comorbidities all affect eligibility
- check_circleBiomarker testing (NGS, IHC, flow cytometry) is often required before applying for advanced therapy
- check_circleCancerFax can review medical records and provide an initial eligibility assessment
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Not Sure If Advanced Treatment Applies to You?
CancerFax reviews your reports to identify which advanced therapies and clinical trials may be relevant for your specific cancer type and stage.
This information is for patient education only. Always consult a qualified oncologist before making treatment decisions.